World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
55
Citations
8572
World Ranking
2290
National Ranking
1127

Gary L. Griffiths publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Gary L. Griffiths sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 158 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Gary L. Griffiths D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Gary L. Griffiths sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 55 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Gary L. Griffiths is affiliated with the National Institutes of Health in the United States, with a research focus spanning medicine, immunology, and microbiology. Their work encompasses multiple subfields including radiology, nuclear medicine and imaging, pulmonary and respiratory medicine, immunology, molecular biology, and oncology.

The scientist's research topics include radiopharmaceutical chemistry and applications, medical imaging techniques and applications, prostate cancer treatment and research, peptidase inhibition and analysis, mass spectrometry techniques and applications, microbial infections and disease research, and immune response and inflammation.

Recent publications authored or co-authored by Gary L. Griffiths highlight their involvement in medical imaging and biochemical research. These publications include:

  • Translating a radiolabeled imaging agent to the clinic, 2021, Advanced Drug Delivery Reviews
  • Preclinical Imaging of Prostate Cancer, 2023, Seminars in Nuclear Medicine
  • Correction: Inhibition of glutathione peroxidase mediates the collateral sensitivity of multidrug-resistant cells to tiopronin, 2020, Journal of Biological Chemistry
  • Correction: Tracking the Luminal Exposure and Lymphatic Drainage Pathways of Intravaginal and Intrarectal Inocula Used in Nonhuman Primate Models of HIV Transmission, 2023, PLoS ONE
  • Retraction of "Collateral Sensitivity of Multidrug-Resistant Cells to the Orphan Drug Tiopronin", 2020, Journal of Medicinal Chemistry

The venues in which they have published include the Journal of Biological Chemistry, Advanced Drug Delivery Reviews, Seminars in Nuclear Medicine, PLoS ONE, and the Journal of Medicinal Chemistry.

Frequent co-authors collaborating with Gary L. Griffiths comprise Peter L. Choyke, Andrew S. Goldsborough, Michael M. Gottesman, Liza Lindenberg, and Esther Mena, indicating interdisciplinary and collaborative research efforts.

Best Publications

  • Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol.

    Xuewei Zhu;John S. Owen;Martha D. Wilson;Haitao Li

  • Preparation and use of immunoconjugates comprising a VL-chain glycosylated at the Asn in position 18

    Seregulam V. Govindan;Gary L. Griffiths;Hans J. Hansen;Shui-On Leung

  • The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels.

    L. B. Shih;S. R. Thorpe;G. L. Griffiths;H. Diril

  • Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.

    Puja Sapra;Rhona Stein;Jennifer Pickett;Zhengxing Qu

  • Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives.

    Thomas M. Behr;Robert M. Sharkey;Malik E. Juweid;Rosalyn D. Blumenthal

  • Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas.

    Hans J Hansen;Gaik Lin Ong;Habibe Diril;Anita Valdez

  • Use of bi-specific antibodies for pre-targeting diagnosis and therapy

    Hans J. Hansen;Gary L. Griffiths;Shui-On Leung;William J. Mcbride

  • (89)Zr-Oxine Complex PET Cell Imaging in Monitoring Cell-based Therapies.

    Noriko Sato;Haitao Wu;Kingsley O. Asiedu;Lawrence P. Szajek

  • Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors

    Unknown

  • A universal pretargeting system for cancer detection and therapy using bispecific antibody.

    Robert M. Sharkey;William J. McBride;Habibe Karacay;Ken Chang

  • Processing of antibody-radioisotope conjugates after binding to the surface of tumor cells

    M. Jules Mattes;Gary L. Griffiths;Habibe Diril;David M. Goldenberg

  • Cure of SCID Mice Bearing Human B-Lymphoma Xenografts by an Anti-CD74 Antibody-Anthracycline Drug Conjugate

    Gary L Griffiths;M Jules Mattes;Rhona Stein;Serengulam V Govindan

  • Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptide.

    H Karacay;W J McBride;G L Griffiths;R M Sharkey

  • 90Y-DOTA-hLL2: An Agent for Radioimmunotherapy of Non-Hodgkin’s Lymphoma

    Gary L. Griffiths;Serengulam V. Govindan;Robert M. Sharkey;Darrell R. Fisher

  • Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates

    David Milton Goldenberg;Gary L. Griffiths;Hans J. Hansen

  • Direct Radiolabeling of Monoclonal Antibodies with Generator-produced Rhenium-188 for Radioimmunotherapy: Labeling and Animal Biodistribution Studies

    Gary L. Griffiths;David M. Goldenberg;Furn F. Knapp;Alvin P. Callahan

  • PRODUCTION AND USE OF NOVEL PEPTIDE-BASED AGENT FOR USE WITH BI-SPECIFIC ANTIBODY

    Hansen Hans J;Griffiths Gary L;Leung Shui-On;Mcbride William J

  • Mitochondrial NADH fluorescence is enhanced by complex I binding.

    Ksenia Blinova;Rodney L. Levine;Emily S. Boja;Gary L. Griffiths

  • Improved Iodine Radiolabels for Monoclonal Antibody Therapy

    Rhona Stein;Serengulam V. Govindan;M. Jules Mattes;Susan Chen

  • Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22

    R M Sharkey;T M Behr;M J Mattes;R Stein

Frequent Co-Authors

Hans J. Hansen
Hans J. Hansen Eisai (Japan)
David M. Goldenberg
David M. Goldenberg Immunomedics (United States)
Robert M. Sharkey
Robert M. Sharkey University of Fukui
Peter L. Choyke
Peter L. Choyke National Institutes of Health
Ivan D. Horak
Ivan D. Horak Freie Universität Berlin
Samuel Achilefu
Samuel Achilefu Washington University in St. Louis
Matthew D. Hall
Matthew D. Hall National Institutes of Health
Ronald M. Summers
Ronald M. Summers National Institutes of Health
Chien-Hsing Chang
Chien-Hsing Chang Northwestern University
Hisataka Kobayashi
Hisataka Kobayashi National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology often opens doors to various online study options and interdisciplinary careers. For those interested in blending life sciences with other fields, considering an online interdisciplinary studies tuition costs review can help identify programs that suit both your academic and financial preferences.

If you’re keen on integrating biological sciences with quantitative skills, pursuing a degree from an online degree mathematics program can be a smart move, particularly for research and data-driven roles. Alternatively, those who want to leverage their scientific knowledge creatively can explore study options at online graphic design schools.

The world of biology frequently overlaps with structural sciences—making an architecture degree online an interesting pathway, especially for careers in bio-architecture or sustainable design. Whether you aim for research, design, or analytical roles, these diverse online degrees can expand your career opportunities beyond traditional molecular biology paths.

Best Scientists Citing Gary L. Griffiths

Trending Scientists

Recently Published Articles